Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Locally Advanced Pancreatic Ductal Adenocarcinoma · Metastatic Pancreatic Ductal Adenocarcinoma · Stage II Pancreatic Cancer AJCC v8 · Stage III Pancreatic Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8 · Unresectable Pancreatic Ductal Adenocarcinoma · Borderline Resectable Pancreatic Ductal Adenocarcinoma · Resectable Pancreatic Ductal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
OHSU Knight Cancer Institute, Portland, Oregon, United States
Contact: Principal Investigator (Charles D. Lopez)
Study leads
Charles D Lopez
Principal Investigator
OHSU Knight Cancer Institute